Tirzepatide, a novel medication, is sparking significant buzz in the scientific community as a potential treatment for both type 2 diabetes and weight loss . This dual-action drug works by targeting two different receptors, GLP-1 and GIP, leading to improved glycemic management and significant slimming in research studies . While preliminary findin